Provivi

• ·Provivi’s last known valuation is $420.0M (Mar 2021).
• ·It has raised $248.1M across 6 recorded rounds; the latest was Early Stage VC ($25.5M) in Sep 2025.
• ·Notable investors include US National Science Foundation, Temasek Holdings, Gates Foundation, Vivo Capital, BASF Venture Capital — 13 tracked in total.
• ·2 investment vehicles were formed to buy Provivi shares in the last 12 months, reporting $4.7M sold to 54 investors, per SEC Form D filings.
• ·Provivi has filed 10 Form Ds with the SEC since 2015, most recently Oct 2019 ($85.0M sold to 21 investors).
• ·Status: Privately Held (backing).

In the last 12 months, 2 investment vehicles were formed to buy Provivi shares, reporting $4.7M sold to 54 investors. Most recent filing Mar 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

Developer of insect pheromones designed to protect food supplies without toxic residues. The company's pheromones are designed to create a new foundation for safe, affordable, and sustainable crop protection, enabling farmers to protect crops in a naturally effective and sustainable way.

Sector

Materials and Resources

HQ

Santa Monica, CA, United States

Founded

2013

Employees

83

Website

provivi.com/

Ownership

Privately Held (backing)